Challenging this paradigm has been the discovery of the TAZ-CAMTA1 [36–38] and YAP-TFE3 [39] fusion proteins in epithelioid hemangioendothelioma (EHE), a vascular sarcoma. This evidence concerns the gene CAMTA1 and epithelioid hemangioendothelioma.